nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP2C9—Teniposide—lymphatic system cancer	0.117	0.294	CbGbCtD
Sulfamethoxazole—CYP3A4—Cytarabine—lymphatic system cancer	0.069	0.174	CbGbCtD
Sulfamethoxazole—CYP3A4—Teniposide—lymphatic system cancer	0.0679	0.171	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—lymphatic system cancer	0.0632	0.159	CbGbCtD
Sulfamethoxazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0475	0.12	CbGbCtD
Sulfamethoxazole—CYP3A4—Vincristine—lymphatic system cancer	0.0327	0.0823	CbGbCtD
Sulfamethoxazole—Leukopenia—Teniposide—lymphatic system cancer	0.00234	0.00389	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00231	0.00384	CcSEcCtD
Sulfamethoxazole—Malnutrition—Fludarabine—lymphatic system cancer	0.0023	0.00382	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Bleomycin—lymphatic system cancer	0.0023	0.00382	CcSEcCtD
Sulfamethoxazole—Ataxia—Carmustine—lymphatic system cancer	0.0023	0.00382	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00228	0.00379	CcSEcCtD
Sulfamethoxazole—Ataxia—Vincristine—lymphatic system cancer	0.0022	0.00364	CcSEcCtD
Sulfamethoxazole—Pneumonia—Bleomycin—lymphatic system cancer	0.00217	0.0036	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00214	0.00354	CcSEcCtD
Sulfamethoxazole—Stomatitis—Bleomycin—lymphatic system cancer	0.00211	0.00349	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00209	0.00347	CcSEcCtD
Sulfamethoxazole—Leukopenia—Fludarabine—lymphatic system cancer	0.00206	0.00342	CcSEcCtD
Sulfamethoxazole—Pruritus—Mechlorethamine—lymphatic system cancer	0.00205	0.0034	CcSEcCtD
Sulfamethoxazole—Anorexia—Teniposide—lymphatic system cancer	0.00204	0.00338	CcSEcCtD
Sulfamethoxazole—Cough—Fludarabine—lymphatic system cancer	0.00201	0.00333	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Carmustine—lymphatic system cancer	0.00201	0.00333	CcSEcCtD
Sulfamethoxazole—Convulsion—Fludarabine—lymphatic system cancer	0.00199	0.00331	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00198	0.00329	CcSEcCtD
Sulfamethoxazole—Neutropenia—Carmustine—lymphatic system cancer	0.00198	0.00328	CcSEcCtD
Sulfamethoxazole—Arthralgia—Fludarabine—lymphatic system cancer	0.00196	0.00325	CcSEcCtD
Sulfamethoxazole—Myalgia—Fludarabine—lymphatic system cancer	0.00196	0.00325	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Vincristine—lymphatic system cancer	0.00192	0.00318	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Teniposide—lymphatic system cancer	0.00191	0.00316	CcSEcCtD
Sulfamethoxazole—Pneumonia—Carmustine—lymphatic system cancer	0.0019	0.00315	CcSEcCtD
Sulfamethoxazole—Neutropenia—Vincristine—lymphatic system cancer	0.00189	0.00313	CcSEcCtD
Sulfamethoxazole—Depression—Carmustine—lymphatic system cancer	0.00188	0.00312	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00188	0.00312	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00187	0.0031	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Teniposide—lymphatic system cancer	0.00186	0.00308	CcSEcCtD
Sulfamethoxazole—Renal failure—Carmustine—lymphatic system cancer	0.00185	0.00307	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00185	0.00307	CcSEcCtD
Sulfamethoxazole—Vomiting—Mechlorethamine—lymphatic system cancer	0.00184	0.00306	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00184	0.00306	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00184	0.00306	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00184	0.00305	CcSEcCtD
Sulfamethoxazole—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00184	0.00305	CcSEcCtD
Sulfamethoxazole—Stomatitis—Carmustine—lymphatic system cancer	0.00184	0.00305	CcSEcCtD
Sulfamethoxazole—Rash—Mechlorethamine—lymphatic system cancer	0.00183	0.00303	CcSEcCtD
Sulfamethoxazole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00183	0.00303	CcSEcCtD
Sulfamethoxazole—Pneumonia—Vincristine—lymphatic system cancer	0.00181	0.003	CcSEcCtD
Sulfamethoxazole—Depression—Vincristine—lymphatic system cancer	0.00179	0.00298	CcSEcCtD
Sulfamethoxazole—Anorexia—Fludarabine—lymphatic system cancer	0.00179	0.00297	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00176	0.00293	CcSEcCtD
Sulfamethoxazole—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00176	0.00292	CcSEcCtD
Sulfamethoxazole—Stomatitis—Vincristine—lymphatic system cancer	0.00175	0.00291	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00175	0.0029	CcSEcCtD
Sulfamethoxazole—Chills—Bleomycin—lymphatic system cancer	0.00174	0.00289	CcSEcCtD
Sulfamethoxazole—Renal failure—Mitoxantrone—lymphatic system cancer	0.00172	0.00286	CcSEcCtD
Sulfamethoxazole—Nausea—Mechlorethamine—lymphatic system cancer	0.00172	0.00286	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00171	0.00284	CcSEcCtD
Sulfamethoxazole—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00171	0.00283	CcSEcCtD
Sulfamethoxazole—Urticaria—Teniposide—lymphatic system cancer	0.0017	0.00282	CcSEcCtD
Sulfamethoxazole—Glossitis—Methotrexate—lymphatic system cancer	0.00169	0.00281	CcSEcCtD
Sulfamethoxazole—Oliguria—Methotrexate—lymphatic system cancer	0.00169	0.00281	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Teniposide—lymphatic system cancer	0.00169	0.0028	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Teniposide—lymphatic system cancer	0.00169	0.0028	CcSEcCtD
Sulfamethoxazole—Hallucination—Carmustine—lymphatic system cancer	0.00168	0.00279	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Fludarabine—lymphatic system cancer	0.00168	0.00278	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00166	0.00276	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Fludarabine—lymphatic system cancer	0.00165	0.00274	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00165	0.00274	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00164	0.00271	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Fludarabine—lymphatic system cancer	0.00163	0.00271	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00162	0.00269	CcSEcCtD
Sulfamethoxazole—Fatigue—Fludarabine—lymphatic system cancer	0.00162	0.00269	CcSEcCtD
Sulfamethoxazole—Hallucination—Vincristine—lymphatic system cancer	0.00161	0.00267	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Vincristine—lymphatic system cancer	0.0016	0.00265	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00159	0.00263	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Vincristine—lymphatic system cancer	0.00158	0.00263	CcSEcCtD
Sulfamethoxazole—Eye disorder—Carmustine—lymphatic system cancer	0.00158	0.00262	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Teniposide—lymphatic system cancer	0.00158	0.00261	CcSEcCtD
Sulfamethoxazole—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00157	0.00261	CcSEcCtD
Sulfamethoxazole—Asthenia—Teniposide—lymphatic system cancer	0.00153	0.00254	CcSEcCtD
Sulfamethoxazole—Pruritus—Teniposide—lymphatic system cancer	0.00151	0.00251	CcSEcCtD
Sulfamethoxazole—Leukopenia—Bleomycin—lymphatic system cancer	0.00151	0.00251	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00149	0.00246	CcSEcCtD
Sulfamethoxazole—Mental disorder—Carmustine—lymphatic system cancer	0.00148	0.00246	CcSEcCtD
Sulfamethoxazole—Malnutrition—Carmustine—lymphatic system cancer	0.00147	0.00244	CcSEcCtD
Sulfamethoxazole—Cough—Bleomycin—lymphatic system cancer	0.00147	0.00244	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00147	0.00243	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Teniposide—lymphatic system cancer	0.00146	0.00243	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00146	0.00242	CcSEcCtD
Sulfamethoxazole—Myalgia—Bleomycin—lymphatic system cancer	0.00144	0.00238	CcSEcCtD
Sulfamethoxazole—Mental disorder—Vincristine—lymphatic system cancer	0.00142	0.00235	CcSEcCtD
Sulfamethoxazole—Chills—Mitoxantrone—lymphatic system cancer	0.00141	0.00234	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00138	0.0023	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00138	0.00229	CcSEcCtD
Sulfamethoxazole—Vomiting—Teniposide—lymphatic system cancer	0.00136	0.00225	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00135	0.00224	CcSEcCtD
Sulfamethoxazole—Asthenia—Fludarabine—lymphatic system cancer	0.00135	0.00224	CcSEcCtD
Sulfamethoxazole—Rash—Teniposide—lymphatic system cancer	0.00135	0.00224	CcSEcCtD
Sulfamethoxazole—Dermatitis—Teniposide—lymphatic system cancer	0.00135	0.00223	CcSEcCtD
Sulfamethoxazole—Headache—Teniposide—lymphatic system cancer	0.00134	0.00222	CcSEcCtD
Sulfamethoxazole—Pruritus—Fludarabine—lymphatic system cancer	0.00133	0.00221	CcSEcCtD
Sulfamethoxazole—Leukopenia—Carmustine—lymphatic system cancer	0.00132	0.00219	CcSEcCtD
Sulfamethoxazole—Anorexia—Bleomycin—lymphatic system cancer	0.00131	0.00218	CcSEcCtD
Sulfamethoxazole—Polyuria—Methotrexate—lymphatic system cancer	0.00129	0.00214	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Methotrexate—lymphatic system cancer	0.00129	0.00214	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.00129	0.00213	CcSEcCtD
Sulfamethoxazole—Convulsion—Carmustine—lymphatic system cancer	0.00128	0.00212	CcSEcCtD
Sulfamethoxazole—Nausea—Teniposide—lymphatic system cancer	0.00127	0.00211	CcSEcCtD
Sulfamethoxazole—Vertigo—Vincristine—lymphatic system cancer	0.00126	0.0021	CcSEcCtD
Sulfamethoxazole—Leukopenia—Vincristine—lymphatic system cancer	0.00126	0.00209	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00126	0.00208	CcSEcCtD
Sulfamethoxazole—Myalgia—Carmustine—lymphatic system cancer	0.00125	0.00208	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Bleomycin—lymphatic system cancer	0.00123	0.00204	CcSEcCtD
Sulfamethoxazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00123	0.00203	CcSEcCtD
Sulfamethoxazole—Convulsion—Vincristine—lymphatic system cancer	0.00122	0.00202	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.0012	0.00199	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.0012	0.00199	CcSEcCtD
Sulfamethoxazole—Myalgia—Vincristine—lymphatic system cancer	0.0012	0.00199	CcSEcCtD
Sulfamethoxazole—Cough—Mitoxantrone—lymphatic system cancer	0.0012	0.00198	CcSEcCtD
Sulfamethoxazole—Vomiting—Fludarabine—lymphatic system cancer	0.00119	0.00198	CcSEcCtD
Sulfamethoxazole—Convulsion—Mitoxantrone—lymphatic system cancer	0.00119	0.00197	CcSEcCtD
Sulfamethoxazole—Rash—Fludarabine—lymphatic system cancer	0.00118	0.00197	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fludarabine—lymphatic system cancer	0.00118	0.00196	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00118	0.00195	CcSEcCtD
Sulfamethoxazole—Headache—Fludarabine—lymphatic system cancer	0.00118	0.00195	CcSEcCtD
Sulfamethoxazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00117	0.00193	CcSEcCtD
Sulfamethoxazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.00117	0.00193	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00115	0.0019	CcSEcCtD
Sulfamethoxazole—Anorexia—Carmustine—lymphatic system cancer	0.00115	0.0019	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.00113	0.00187	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00112	0.00186	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00112	0.00185	CcSEcCtD
Sulfamethoxazole—Nausea—Fludarabine—lymphatic system cancer	0.00112	0.00185	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0011	0.00182	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00109	0.00182	CcSEcCtD
Sulfamethoxazole—Urticaria—Bleomycin—lymphatic system cancer	0.00109	0.00182	CcSEcCtD
Sulfamethoxazole—Anorexia—Vincristine—lymphatic system cancer	0.00109	0.00182	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.00109	0.00181	CcSEcCtD
Sulfamethoxazole—Insomnia—Carmustine—lymphatic system cancer	0.00109	0.0018	CcSEcCtD
Sulfamethoxazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00109	0.0018	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Carmustine—lymphatic system cancer	0.00107	0.00178	CcSEcCtD
Sulfamethoxazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.00107	0.00177	CcSEcCtD
Sulfamethoxazole—Ataxia—Methotrexate—lymphatic system cancer	0.00107	0.00177	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00105	0.00173	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Carmustine—lymphatic system cancer	0.00105	0.00173	CcSEcCtD
Sulfamethoxazole—Insomnia—Vincristine—lymphatic system cancer	0.00104	0.00172	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00104	0.00172	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00102	0.00169	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00102	0.00169	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00101	0.00168	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vincristine—lymphatic system cancer	0.000998	0.00166	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000997	0.00165	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000991	0.00164	CcSEcCtD
Sulfamethoxazole—Fatigue—Vincristine—lymphatic system cancer	0.00099	0.00164	CcSEcCtD
Sulfamethoxazole—Asthenia—Bleomycin—lymphatic system cancer	0.000988	0.00164	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000984	0.00163	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000983	0.00163	CcSEcCtD
Sulfamethoxazole—Pruritus—Bleomycin—lymphatic system cancer	0.000975	0.00162	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000972	0.00161	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—lymphatic system cancer	0.00097	0.00161	CcSEcCtD
Sulfamethoxazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000964	0.0016	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—lymphatic system cancer	0.00096	0.00159	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000951	0.00158	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Carmustine—lymphatic system cancer	0.000951	0.00158	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000939	0.00156	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—lymphatic system cancer	0.00093	0.00154	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—lymphatic system cancer	0.000916	0.00152	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000914	0.00152	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vincristine—lymphatic system cancer	0.000907	0.00151	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000907	0.00151	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000894	0.00148	CcSEcCtD
Sulfamethoxazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000888	0.00147	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000886	0.00147	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000884	0.00147	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000884	0.00147	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—lymphatic system cancer	0.000878	0.00146	CcSEcCtD
Sulfamethoxazole—Vomiting—Bleomycin—lymphatic system cancer	0.000876	0.00145	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—lymphatic system cancer	0.000873	0.00145	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—lymphatic system cancer	0.000873	0.00145	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—lymphatic system cancer	0.000871	0.00144	CcSEcCtD
Sulfamethoxazole—Rash—Bleomycin—lymphatic system cancer	0.000869	0.00144	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000868	0.00144	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000866	0.00144	CcSEcCtD
Sulfamethoxazole—Asthenia—Carmustine—lymphatic system cancer	0.000863	0.00143	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—lymphatic system cancer	0.000858	0.00142	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—lymphatic system cancer	0.000851	0.00141	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000846	0.0014	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000826	0.00137	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000824	0.00137	CcSEcCtD
Sulfamethoxazole—Asthenia—Vincristine—lymphatic system cancer	0.000824	0.00137	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Carmustine—lymphatic system cancer	0.000823	0.00136	CcSEcCtD
Sulfamethoxazole—Nausea—Bleomycin—lymphatic system cancer	0.000818	0.00136	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000815	0.00135	CcSEcCtD
Sulfamethoxazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000802	0.00133	CcSEcCtD
Sulfamethoxazole—Dizziness—Carmustine—lymphatic system cancer	0.000795	0.00132	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vincristine—lymphatic system cancer	0.000785	0.0013	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—lymphatic system cancer	0.000784	0.0013	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000774	0.00128	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—lymphatic system cancer	0.000769	0.00127	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000765	0.00127	CcSEcCtD
Sulfamethoxazole—Vomiting—Carmustine—lymphatic system cancer	0.000765	0.00127	CcSEcCtD
Sulfamethoxazole—Dizziness—Vincristine—lymphatic system cancer	0.000759	0.00126	CcSEcCtD
Sulfamethoxazole—Rash—Carmustine—lymphatic system cancer	0.000758	0.00126	CcSEcCtD
Sulfamethoxazole—Dermatitis—Carmustine—lymphatic system cancer	0.000758	0.00126	CcSEcCtD
Sulfamethoxazole—Headache—Carmustine—lymphatic system cancer	0.000753	0.00125	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000741	0.00123	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—lymphatic system cancer	0.000733	0.00122	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—lymphatic system cancer	0.000731	0.00121	CcSEcCtD
Sulfamethoxazole—Vomiting—Vincristine—lymphatic system cancer	0.00073	0.00121	CcSEcCtD
Sulfamethoxazole—Rash—Vincristine—lymphatic system cancer	0.000724	0.0012	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vincristine—lymphatic system cancer	0.000723	0.0012	CcSEcCtD
Sulfamethoxazole—Headache—Vincristine—lymphatic system cancer	0.000719	0.00119	CcSEcCtD
Sulfamethoxazole—Nausea—Carmustine—lymphatic system cancer	0.000714	0.00118	CcSEcCtD
Sulfamethoxazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000711	0.00118	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000708	0.00117	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000707	0.00117	CcSEcCtD
Sulfamethoxazole—Rash—Mitoxantrone—lymphatic system cancer	0.000705	0.00117	CcSEcCtD
Sulfamethoxazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000704	0.00117	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—lymphatic system cancer	0.000703	0.00117	CcSEcCtD
Sulfamethoxazole—Headache—Mitoxantrone—lymphatic system cancer	0.0007	0.00116	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—lymphatic system cancer	0.000687	0.00114	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—lymphatic system cancer	0.000682	0.00113	CcSEcCtD
Sulfamethoxazole—Nausea—Vincristine—lymphatic system cancer	0.000682	0.00113	CcSEcCtD
Sulfamethoxazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000664	0.0011	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—lymphatic system cancer	0.000613	0.00102	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—lymphatic system cancer	0.000611	0.00101	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—lymphatic system cancer	0.000596	0.000988	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—lymphatic system cancer	0.000591	0.000981	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—lymphatic system cancer	0.000581	0.000964	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—lymphatic system cancer	0.000581	0.000964	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000577	0.000957	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000557	0.000924	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000546	0.000906	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000545	0.000905	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000541	0.000897	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—lymphatic system cancer	0.000531	0.000881	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000507	0.000842	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—lymphatic system cancer	0.000504	0.000836	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—lymphatic system cancer	0.000497	0.000824	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.00049	0.000813	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000484	0.000803	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000481	0.000798	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—lymphatic system cancer	0.00048	0.000797	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000455	0.000756	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—lymphatic system cancer	0.000442	0.000734	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.00044	0.00073	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.00044	0.00073	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00041	0.000681	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—lymphatic system cancer	0.0004	0.000663	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—lymphatic system cancer	0.000394	0.000654	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000381	0.000632	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—lymphatic system cancer	0.000368	0.000611	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—lymphatic system cancer	0.000354	0.000587	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—lymphatic system cancer	0.000351	0.000583	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000351	0.000582	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—lymphatic system cancer	0.000349	0.000579	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—lymphatic system cancer	0.000331	0.000549	CcSEcCtD
